title: [Pap smear for mass screening: Results of an African experiment].
abstract: OBJECTIVE
  To assess the impact of smear test in the fight against cervix uteri cancer in Senegal.
  
  
  METHODS
  This was a descriptive cross-sectional study of 1836 Pap smears performed in patients over 15 years during several screening campaigns in Senegal conducted between June 2010 and June 2012. We analyzed epidemiological data, pathological smears, and the proposed management.
  
  
  RESULTS
  In 69% of cases, the women were less than 45 years old. They were mostly multiparous and did not use contraceptive methods before. The smears were interpreted in 91.4% (n=1661) and were pathological in 5.2% of cases. They revealed mainly atypical squamous cells of undetermined significance, squamous intraepithelial low-grade lesions, and squamous intraepithelial high-grade lesions, respectively in 2.5% (n=46), 1.7% (n=30) and 1% (n=19) of cases. Multiparity, early marriages were the main risk factors. Patients with pathological smars had colposcopy with cryotherapy (23 cases), and colposcopy and biopsy (13 cases). A hysterectomy was performed in 4 cases.
  
  
  CONCLUSIONS
  The pathological smear rate found in this study confirms the interest to continue cervical cancer screening with this practice. Strengthening of its geographical and financial access through a national prevention program will effectively help to lower cases of cervical cancer.
authors.affiliation: Institut du cancer, hôpital Aristide-Le-Dantec de Dakar, BP 15647, Dakar, Sénégal; Unité de cancérologie, service de chirurgie générale, institut supérieur des sciences de la santé, université polytechnique de Bobo Dioulasso, CHU Souro Sanou, Bobo Dioulasso, Burkina Faso. Electronic address: som_roll@yahoo.fr.
authors.forename: O-R
authors.initials: OR
authors.lastname: Somé
authors.affiliation: Centre médical Medisol international de Dakar, Dakar, Sénégal.
authors.forename: N
authors.initials: N
authors.lastname: Zongo
authors.affiliation: Institut du cancer, hôpital Aristide-Le-Dantec de Dakar, BP 15647, Dakar, Sénégal; Université Cheikh Anta Diop de Dakar - UCAD, Dakar, Sénégal.
authors.forename: S
authors.initials: S
authors.lastname: Ka
authors.affiliation: Centre médical Medisol international de Dakar, Dakar, Sénégal; Service de chirurgie générale, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso.
authors.forename: R
authors.initials: R
authors.lastname: Wardini
authors.affiliation: Institut du cancer, hôpital Aristide-Le-Dantec de Dakar, BP 15647, Dakar, Sénégal; Université Cheikh Anta Diop de Dakar - UCAD, Dakar, Sénégal.
authors.forename: A
authors.initials: A
authors.lastname: Dem
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D065309:Atypical Squamous Cells of the Cervix / Q000473:pathology; D002584:Cervix Uteri / Q000473:pathology; D003127:Colposcopy; D003268:Contraception Behavior; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008403:Mass Screening; D008875:Middle Aged; D065006:Papanicolaou Test; D010298:Parity; D012307:Risk Factors; D012675:Senegal / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000601:surgery; D055815:Young Adult; D002578:Uterine Cervical Dysplasia / Q000473:pathology
keywords: Biopsie; Biopsy; Cervical smear; Colposcopie; Colposcopy; Cryotherapy; Cryothérapie; Frottis cervicovaginal